Latest return on equity
Neuphoria Therapeutics Inc. Return on equity
Neuphoria Therapeutics Inc. (NEUP) return on equity with its verified observati…
Direct answer
Neuphoria Therapeutics Inc.'s return on equity is -62.9%.
The verified market snapshot reports -62.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 14, 2026.
Get free Neuphoria Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -62.9%
Explore related company data
View Neuphoria Therapeutics Inc.'s market capitalizationView Neuphoria Therapeutics Inc.'s price-to-book ratioView Neuphoria Therapeutics Inc.'s 52-week price rangeView Neuphoria Therapeutics Inc.'s profit marginView Neuphoria Therapeutics Inc.'s debt-to-equity ratioView all Neuphoria Therapeutics Inc. key metricsReturn to Neuphoria Therapeutics Inc. profile